Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfentanil plus propofol versus sufentanil plus propofol for sedation during fiberoptic bronchoscopy
ChiCTR2600131294Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Nantong University
- Start
- Sep 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of alfentanil, sufentanil and propofol (2 arms), sponsored by Affiliated Hospital of Nantong University. Primary endpoints: Incidence of intraoperative respiratory depression and Success rate of anesthesia without intraoperative respiratory or circulatory depression. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
alfentanilsufentanilpropofol
Beyond the preview
Go deeper on ChiCTR2600131294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600131294.